
Michael de Marco, vice president of commercial development for Lonza’s Integrated Biologics Platform, told
earlier this month that Vacaville’s large-scale mammalian capacity is well-suited for the current market environment.
“Vacaville is a super interesting site for many clients,” de Marco said. “We’re not really lacking any interest.”
As Editor in Chief, Greg oversees all aspects of planning, managing and producing the content for Pharma Manufacturing’s print magazines, website, digital products, and in-person events, as well as the daily operations of its editorial team.
For more than 20 years, Greg has covered the healthcare, life sciences, and medical device industries for several trade publications. He is the recipient of a Post-Newsweek Business Information Editorial Excellence Award for his news reporting and a Gold Award for Best Case Study from the American Society of Healthcare Publication Editors. In addition, Greg is a Healthcare Fellow from the Society for Advancing Business Editing and Writing.
When not covering the pharma manufacturing industry, he is an avid Buffalo Bills football fan, likes to kayak and plays guitar.











